Corbett TH - Search Results

1

Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH. Luesch H, et al. Among authors: corbett th. J Nat Prod. 2001 Jul;64(7):907-10. doi: 10.1021/np010049y. J Nat Prod. 2001. PMID: 11473421

2

Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.

Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL, Corbett TH. Luesch H, et al. Among authors: corbett th. J Nat Prod. 2002 Jan;65(1):16-20. doi: 10.1021/np010317s. J Nat Prod. 2002. PMID: 11809057

3

Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.

Harrigan GG, Luesch H, Yoshida WY, Moore RE, Nagle DG, Paul VJ, Mooberry SL, Corbett TH, Valeriote FA. Harrigan GG, et al. Among authors: corbett th. J Nat Prod. 1998 Sep;61(9):1075-7. doi: 10.1021/np980321c. J Nat Prod. 1998. PMID: 9748368

4

Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.

Harrigan GG, Yoshida WY, Moore RE, Nagle DG, Park PU, Biggs J, Paul VJ, Mooberry SL, Corbett TH, Valeriote FA. Harrigan GG, et al. Among authors: corbett th. J Nat Prod. 1998 Oct;61(10):1221-5. doi: 10.1021/np9801211. J Nat Prod. 1998. PMID: 9784156

5

Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.

Luesch H, Yoshida WY, Moore RE, Paul VJ, Corbett TH. Luesch H, et al. Among authors: corbett th. J Am Chem Soc. 2001 Jun 13;123(23):5418-23. doi: 10.1021/ja010453j. J Am Chem Soc. 2001. PMID: 11389621

6

The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog.

Mooberry SL, Leal RM, Tinley TL, Luesch H, Moore RE, Corbett TH. Mooberry SL, et al. Among authors: corbett th. Int J Cancer. 2003 Apr 20;104(4):512-21. doi: 10.1002/ijc.10982. Int J Cancer. 2003. PMID: 12584751 Free article.

7

Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.

Liang J, Moore RE, Moher ED, Munroe JE, Al-awar RS, Hay DA, Varie DL, Zhang TY, Aikins JA, Martinelli MJ, Shih C, Ray JE, Gibson LL, Vasudevan V, Polin L, White K, Kushner J, Simpson C, Pugh S, Corbett TH. Liang J, et al. Among authors: corbett th. Invest New Drugs. 2005 Jun;23(3):213-24. doi: 10.1007/s10637-005-6729-9. Invest New Drugs. 2005. PMID: 15868377

8

A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.

Al-Awar RS, Ray JE, Schultz RM, Andis SL, Kennedy JH, Moore RE, Liang J, Golakoti T, Subbaraju GV, Corbett TH. Al-Awar RS, et al. Among authors: corbett th. J Med Chem. 2003 Jul 3;46(14):2985-3007. doi: 10.1021/jm0203884. J Med Chem. 2003. PMID: 12825938

9

Isolation and cytotoxic evaluation of marine sponge-derived norterpene peroxides.

Sperry S, Valeriote FA, Corbett TH, Crews P. Sperry S, et al. Among authors: corbett th. J Nat Prod. 1998 Feb;61(2):241-7. doi: 10.1021/np970467w. J Nat Prod. 1998. PMID: 9514009

10

Preclinical anticancer activity of cryptophycin-8.

Corbett TH, Valeriote FA, Demchik L, Polin L, Panchapor C, Pugh S, White K, Knight J, Jones J, Jones L, LoRusso P, Foster B, Wiegand RA, Lisow L, Golakoti T, Heltzel CE, Ogino J, Patterson GM, Moore RE. Corbett TH, et al. J Exp Ther Oncol. 1996 Mar;1(2):95-108. J Exp Ther Oncol. 1996. PMID: 9414393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page